Ribomic Inc
TSE:4591
Ribomic Inc
TSE:4591
Price:
84 JPY
-1.18%
Market Closed
Updated:
May 17, 2024
Ribomic Inc
Income from Continuing Operations
|
Ribomic Inc
Income from Continuing Operations Peer Comparison
Comparables:
2160
4587
4974
2929
S
4599
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Ribomic Inc
TSE:4591
|
Income from Continuing Operations
-¥979.1m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
GNI Group Ltd
TSE:2160
|
Income from Continuing Operations
¥9.5B
|
CAGR 3-Years
91%
|
CAGR 5-Years
118%
|
CAGR 10-Years
N/A
|
|
|
PeptiDream Inc
TSE:4587
|
Income from Continuing Operations
¥3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Takara Bio Inc
TSE:4974
|
Income from Continuing Operations
¥1.5B
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
0%
|
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Income from Continuing Operations
¥4.8B
|
CAGR 3-Years
39%
|
CAGR 5-Years
39%
|
CAGR 10-Years
40%
|
|
S
|
StemRIM Inc
TSE:4599
|
Income from Continuing Operations
¥168.4m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Ribomic Inc's Income from Continuing Operations?
Income from Continuing Operations
-979.1m
JPY
-979.1m
JPY
Based on the financial report for Dec 31, 2023, Ribomic Inc's Income from Continuing Operations amounts to -979.1m JPY.
What is Ribomic Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-1%
-1%
Over the last year, the Income from Continuing Operations growth was 52%. The average annual Income from Continuing Operations growth rates for Ribomic Inc have been 2% over the past three years , -1% over the past five years .
You don't have any saved screeners yet
